Therapix Biosciences and Dekel Pharmaceuticals Sign Binding

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Therapix Biosciences and Dekel Pharmaceuticals Sign Binding Term Sheet Outlining Licensing and Royalty Agreement

TEL AVIV, Israel, Jan. 12, 2015 (GLOBE NEWSWIRE) -- Therapix Bio (TASE: THXBY ) (OTCQB:THXBY) today announced that it has entered into a binding Term Sheet outlining a licensing and royalty agreement with Dekel Pharmaceuticals Ltd., a privately-held Israeli company focused on the development of highly differentiated drugs where a lower effective dose-response can be achieved via the "entourage effect", a clinically-proven benefit of cannabinoid analogs, to treat chronic pain and inflammation. Under the agreement, Dekel has granted Therapix the exclusive worldwide right to develop, manufacture and commercialize combination drug therapies based on Dekel's proprietary technology.

In exchange for granting of this right to Therapix, Dekel will receive an upfront license fee, cash or equity payments based on the achievement of specific development milestones, and a time-limited option to purchase Therapix common stock. Additionally, Dekel will receive a royalty based on a percentage of net revenues from the sale of products developed under the license, or fees received by Therapix for any potential sublicense or assignment of the license. The binding term sheet is subject to the approval of the Therapix shareholders.

Therapix Chief Executive Officer Jan Turek, commented, "This agreement is expected to meaningfully accelerate our development initiatives. With the exclusive worldwide license, we are able to begin pre-clinical and proof-of-concept work on certain of Dekel's key 'entourage effect' product candidates. Initially, we will focus on palmitoylethanolamide (PEA), a synthetic cannabinoid analog that demonstrates the "entourage-effect" when combined with certain other drugs, including steroids, opiates, and cannabinoids. We maintain our belief in the near-term clinical and longer-term commercial potential of the PEA combination therapies conceived by Dekel, and look forward to advancing the development of these product candidates."

About Therapix

Therapix is a biopharmaceutical company focused on acquiring and developing unique synthetic cannabinoid and cannabinoid analog drugs for serious medical conditions. Therapix holds 25% of Lara Pharm, a company engaged in the development of a new generation of medication based on synthetic cannabinoids (active compounds in the marijuana plant). Lara's first product is a unique formulation that allows for the inhalation of pharmaceutical-grade synthetic THC. The Company's portfolio further includes the Anti-CD3 technology, an orally administered antibody for the treatment of various inflammatory diseases such as Non Alcoholic Steato Hepatitis (fatty liver disease).

Joseph Green / Taylor Donovan The Ruth Group (646) 536-7013 / 7017

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PEGATRON Unveils AI and HPC Advances at SC26

Updated Category News Views 154

Revamping AI with High-Density Computing You know, back in the day, AI was just about training models and running basic inference. But now, it's all about these crazy agentic AI tasks—autonomous agents doing things I couldn't have imagined. PEGATRON's Evolution in Infrastructure PEGATRON's latest move at SC26 is a real leap forward in this ongoing AI saga. They're...

Continue Reading
Bona's 2027 Floorcast Finds Wood and Trust Still Win

Updated Category News Views 111

Floors are turning into a long-game purchase again Gray flooring may be limping toward the exit, but the more important signal in Bona's 2027 Floorcast is that homeowners are thinking less like bargain hunters and more like custodians of an expensive asset. That is a useful read for anybody watching the home-improvement and maintenance landscape. People do not replace a...

Continue Reading
Animal Parasite Market Growth Has a Resistance Catch

Updated Category News Views 61

Flea collars and cattle worms do not sound glamorous, yet this is exactly where durable animal-health revenue gets built. Wissen Research puts the global animal parasiticides market at $13.6 billion in 2026 and projects $18.6 billion by 2031, a 6.5% compound annual growth rate. That is respectable, not moonshot stuff, and frankly that is part of the appeal. Pet owners...

Continue Reading
Zettia R. Barnes: Charting a Path in Home Healthcare

Updated Category News Views 146

The Lifeline of Home Healthcare in DeSoto You know, it ain't every day that someone like Zettia R. Barnes steps up in the realm of home healthcare and makes a mark that genuinely sticks. From rubbing shoulders with patients to steering a whole dang organization like Angels of Hands Home Health Agency Corp., she's got her hands full—and frankly, it’s folks like her who...

Continue Reading
BWIN Acquisition Under Scrutiny: Shareholders Alerted

Updated Category News Views 137

BWIN Shareholders in the Hot Seat Over Acquisition Ever feel like you're the last one to know when the music stops in this investing dance? Well, if you're holding shares of The Baldwin Insurance Group, Inc. (NASDAQ:BWIN), it's time to put down your coffee and tune in. Levi & Korsinsky, LLP threw a wrench in the works, launching an investigation to see if this Sequence...

Continue Reading
Charter’s $1.5 Billion Tender Tests Debt Discipline

Updated Category News Views 0

Debt cleanup arrives with a hard ceiling Eight far-dated bond issues just got a very specific invitation from Charter Communications: hand them over for cash, but do not expect the company to write a blank check. Charter set final pricing on November 17 for tender offers covering up to $1.5 billion in aggregate consideration, excluding accrued interest and deal expenses....

Continue Reading
Bank of America AML Claims Put Controls Under Fire

Updated Category News Views 0

A $1.2 billion compliance bill has a way of making investors stop pretending controls are boring. Moore Law PLLC is urging Bank of America shareholders to contact the firm over allegations tied to the bank's anti-money-laundering and Bank Secrecy Act systems. The notice follows what it describes as landmark October 13, 2026 enforcement actions by the Treasury Department's...

Continue Reading
SGRY Acquisition Under Scrutiny: Fairness Questioned

Updated Category News Views 232

Questions Hover Over SGRY Acquisition Here's a real jaw-dropper for you. Surgery Partners, Inc. (NASDAQ: SGRY) is getting clocks cleaned in a fairness probe over its acquisition terms. If you thought this ride was smooth, think again—Levi & Korsinsky, LLP has put the brakes on any such assumptions, launching an investigation that’s sure to raise some eyebrows. What's...

Continue Reading
Lake Ridge's Strong Quarter Meets a Book Value Hit

Updated Category News Views 60

An $8.25-per-share securities markdown is the splinter in an otherwise sturdy third-quarter report from Lake Ridge Bancorp. The bank earned $9.8 million, or $4.97 per common share, for the quarter ended September 30, 2026. That is up from $9.0 million, or $4.59 per share, in the prior quarter and $7.7 million, or $3.94 per share, a year earlier. Those are not flimsy...

Continue Reading
Caracal’s $200K VMI Pledge Targets Cadet Affordability

Updated Category News Views 88

A tuition award can still leave a brutal hole in the budget. That is the plain fact sitting underneath Caracal Products & Services’ $200,000 commitment to Virginia Military Institute. Federal ROTC scholarships can cover tuition, but VMI says room, board and quartermaster fees average about $15,000 annually. For a student who has done everything right—earned the ROTC...

Continue Reading

Top 5 Most Recently Viewed Articles

Hexaware Technologies Teams Up with Sports Legend Rahul Dravid

Updated Category News Views 361

Hexaware Welcomes Rahul Dravid as Cultural Ambassador Hexaware Technologies, renowned for its innovation in IT services, has proudly announced the appointment of Rahul Dravid as its cultural ambassador. A celebrated cricket icon and former captain, Dravid is admired not only for his sports achievements but also for his qualities of perseverance and integrity. His...

Continue Reading
Exploring the Surge of the Corrosion Monitoring Market

Updated Category News Views 259

Understanding the Corrosion Monitoring Market The corrosion monitoring market is currently experiencing remarkable growth, driven primarily by a surge in demand for predictive maintenance and managing asset integrity within a wide array of industrial sectors. The market, valued at approximately USD 351.17 million recently, is anticipated to reach USD 916.02 million by...

Continue Reading
Morgan Stanley Stock Performance: Surging to New Heights

Updated Category News Views 262

Morgan Stanley Reaches New Stock Price Milestone Morgan Stanley's shares have hit an impressive new high, reaching a staggering price of $109.12 per share. This notable achievement marks a significant uptick for the investment banking giant, showcasing a remarkable one-year growth of 36.08%. This surge not only highlights Morgan Stanley's strength in a competitive market...

Continue Reading
American Healthcare REIT Expands Footprint with Trilogy Buyout

Updated Category News Views 118

American Healthcare REIT Completes Acquisition of Trilogy Holdings American Healthcare REIT, Inc. (NYSE: AHR) has made a notable move in the healthcare field by fully acquiring Trilogy REIT Holdings, LLC. This acquisition is an important milestone for the company, as it now owns all of Trilogy Holdings and its Integrated Senior Health Campuses (ISHC). Acquisition Details...

Continue Reading
Pieridae Energy Announces Year-End Conference Call Details

Updated Category News Views 219

Pieridae Energy to Discuss Year-End Results in Upcoming Call Pieridae Energy Limited (TSX: PEA) is gearing up for an important event where it will unveil its financial and operational results for the fourth quarter and year-end. This significant release is scheduled for a Wednesday, after the markets close. The anticipation surrounding the company's performance reflects...

Continue Reading